CA2112488A1 - Method and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron - Google Patents

Method and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron

Info

Publication number
CA2112488A1
CA2112488A1 CA002112488A CA2112488A CA2112488A1 CA 2112488 A1 CA2112488 A1 CA 2112488A1 CA 002112488 A CA002112488 A CA 002112488A CA 2112488 A CA2112488 A CA 2112488A CA 2112488 A1 CA2112488 A1 CA 2112488A1
Authority
CA
Canada
Prior art keywords
ondansetron
administered
composition according
pharmaceutically acceptable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002112488A
Other languages
English (en)
French (fr)
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2112488A1 publication Critical patent/CA2112488A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002112488A 1991-06-26 1992-06-25 Method and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron Abandoned CA2112488A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US721,723 1985-04-10
US750,801 1985-07-01
US72172391A 1991-06-26 1991-06-26
US75080191A 1991-08-27 1991-08-27

Publications (1)

Publication Number Publication Date
CA2112488A1 true CA2112488A1 (en) 1993-01-07

Family

ID=27110471

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002112488A Abandoned CA2112488A1 (en) 1991-06-26 1992-06-25 Method and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron

Country Status (5)

Country Link
EP (1) EP0591395A1 (enrdf_load_stackoverflow)
JP (1) JPH06509073A (enrdf_load_stackoverflow)
AU (1) AU2254692A (enrdf_load_stackoverflow)
CA (1) CA2112488A1 (enrdf_load_stackoverflow)
WO (1) WO1993000075A1 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1022025A3 (en) * 1991-06-26 2002-06-05 Sepracor, Inc. Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
CN1078465C (zh) * 1996-10-10 2002-01-30 沈阳药科大学 一种含奥坦西酮的透皮吸收制剂
AU779696B2 (en) 1999-03-01 2005-02-10 Sepracor, Inc. Methods for treating apnea and apnea disorders using optically pure R(+)ondansetron
US20030114475A1 (en) * 2001-10-31 2003-06-19 Addiction Therapies, Inc. Methods for the treatment of addiction
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
NZ222950A (en) * 1986-12-17 1997-06-24 Glaxo Group Ltd Use of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl] -4h- carbazol-4-one for the manufacture of medicaments

Also Published As

Publication number Publication date
JPH06509073A (ja) 1994-10-13
EP0591395A1 (en) 1994-04-13
AU2254692A (en) 1993-01-25
EP0591395A4 (enrdf_load_stackoverflow) 1994-08-31
WO1993000075A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
US5962494A (en) Methods for treating behavioral and other disorders using optically pure R(+) ondansetron
US5786357A (en) Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
EP0861081B1 (de) Verwendung von epinastin für die behandlung von schmerzen
DE69610323T2 (de) Sich schnell im munde auflösende zusammensetzungen für dopaminagonisten
US8420624B2 (en) Methods for treating or preventing symptoms of hormonal variations
EP0663828B1 (en) Treating allergic rhinitis and asthma using (-) Cetirizine
KR100422492B1 (ko) 중추신경계 질환을 치료하는데 유용한 광학적으로 순수한 (+)노르시사프라이드
DE3822792A1 (de) Neue anwendung von 5-ht(pfeil abwaerts)3(pfeil abwaerts) antagonisten
EP1145715A2 (en) Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
CA2139636A1 (en) Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
Farthing 5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists
JPH08501083A (ja) アレルギー疾患治療のためのノルアステミゾールの使用
EP4585210A1 (en) Compound slow-release implant of naltrexone and risperidone, preparation method therefor, and use thereof
CA2112488A1 (en) Method and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
WO1993010787A1 (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
EP2130539A1 (en) Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia
WO2006072413A1 (de) Verwendung ausgewählter cgrp-antagonisten in kombination mit anderen arzneistoffen gegen migräne für die behandlung von migräne
AU3675299A (en) Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron
AU3143402A (en) Methods and compositions for treating emesis, nausea and other disorders using optically pure R() ondansetron
IE903278A1 (en) Use of dopamine-autoreceptor agonists in the treatment of¹drug dependency
CA1110170A (en) Antihypertensive compositions
US4904673A (en) Agent for treating bradycardia and bradyarrhythmia
WO1993010788A1 (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone
WO2001052854A1 (de) Nk1-rezeptor-antagonisten zur behandlung des restless legs syndroms
JPH01168615A (ja) 制吐作用薬剤

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19970625